In the News: October Regulatory and Development Updates
Camargo
NOVEMBER 11, 2020
In November 2017, Foundation Medicine received approval for FoundationOne CDx , a genomic profiling test for solid state tumors, which paved the way for partnerships with pharma companies’ therapeutics. Prior to the availability of this test, Bayer struggled to find patients for its new drug.
Let's personalize your content